Eze L C, Obidoa O
Biochem Genet. 1978 Dec;16(11-12):1073-7. doi: 10.1007/BF00484527.
Sulfamethazine (syn, sulfadimidine) is inactivated by conversion to its N-acetyl derivative. Individuals are phenotyped as either "rapid" or "slow" acetylators. We have tested the validity of this theory in a Nigerian population. The frequency distribution histograms of the percentage acetylsulfamethazine in urine and serum were found to be bimodal, indicating the existence of a genetic polymorphism as observed by earlier workers. A plot of the percentage of the drug acetylated in serum against that in urine of the same individual results in a satisfactory separation of the rapid and slow acetylator phenotypes. An incidence of the slow acetylator phenotype of 41% was observed in the Nigerian population tested. How this observation fits into the hypothesis that the slow frequency of the allele increases from the Arctic Circle toward the Equator is discussed.
磺胺二甲嘧啶(又名磺胺二甲基嘧啶)通过转化为其N - 乙酰衍生物而失活。个体被表型分类为“快速”或“慢速”乙酰化者。我们已经在尼日利亚人群中检验了这一理论的有效性。发现尿和血清中乙酰磺胺二甲嘧啶百分比的频率分布直方图呈双峰,这表明如早期研究者所观察到的那样存在遗传多态性。对同一个体血清中药物乙酰化百分比与尿中药物乙酰化百分比作图,可令人满意地分离出快速和慢速乙酰化者表型。在所检测的尼日利亚人群中,观察到慢速乙酰化者表型的发生率为41%。本文讨论了这一观察结果如何符合等位基因低频从北极圈向赤道增加的假说。